NANOVIRICIDES, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nanoviricides, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Nanoviricides, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 15.6M shares, a 32.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 15.6M +3.86M +32.8% Dec 31, 2024 10-Q 2025-02-14
Q3 2024 14.1M +2.32M +19.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 13.1M +1.45M +12.4% Jun 30, 2024 10-Q 2025-02-14
Q1 2024 11.8M +147K +1.26% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 11.8M +144K +1.24% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 11.7M +136K +1.17% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 11.7M +106K +0.92% Jun 30, 2023 10-K 2024-09-27
Q1 2023 11.7M Mar 31, 2023 10-Q 2023-05-15
Q4 2022 11.6M +100K +0.87% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 11.6M +84.8K +0.74% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 11.6M +77K +0.67% Jun 30, 2022 10-K 2023-10-13
Q4 2021 11.5M +857K +8.03% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 11.5M +859K +8.06% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 11.5M +2.43M +26.8% Jun 30, 2021 10-K 2022-10-13
Q1 2021 11.5M +3.83M +49.9% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 10.7M +6.81M +176% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 10.7M +6.81M +177% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 9.08M +5.24M +136% Jun 30, 2020 10-K 2021-10-12
Q1 2020 7.67M -69.1M -90% Mar 31, 2020 10-Q 2020-06-22
Q4 2019 3.87M -65.6M -94.4% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 3.85M -65.5M -94.4% Sep 30, 2019 10-Q 2019-11-15
Q2 2019 3.84M -65.3M -94.4% Jun 30, 2019 10-K 2020-10-13
Q1 2019 76.7M +7.75M +11.2% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 69.5M +6.13M +9.67% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 69.4M +6.05M +9.55% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 69.2M +5.86M +9.26% Jun 30, 2018 10-K 2019-08-23
Q1 2018 69M +5.91M +9.38% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 63.4M +4.91M +8.41% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 63.3M +5.13M +8.82% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 63.3M +5.13M +8.81% Jun 30, 2017 10-K 2018-10-12
Q1 2017 63.1M +5.1M +8.8% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 58.5M +636K +1.1% Dec 31, 2016 10-Q 2017-02-14
Q3 2016 58.2M +617K +1.07% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 58.2M +938K +1.64% Jun 30, 2016 10-K 2017-09-28
Q1 2016 58M +823K +1.44% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 57.8M +1.26M +2.23% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 57.6M +1.05M +1.86% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 57.2M +2.62M +4.8% Jun 30, 2015 10-K 2016-09-16
Q1 2015 57.2M +2.61M +4.79% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 56.6M +6.52M +13% Dec 31, 2014 10-Q/A 2015-02-25
Q3 2014 56.5M +6.51M +13% Sep 30, 2014 10-Q/A 2015-02-23
Q2 2014 54.6M +7.59M +16.2% Jun 30, 2014 10-K 2015-09-14
Q1 2014 54.5M -110M -66.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 50M -111M -68.9% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 50M -108M -68.4% Sep 30, 2013 10-Q/A 2013-11-18
Q2 2013 47M +2.57M +5.77% Jun 30, 2013 10-K/A 2015-02-23
Q1 2013 165M +10.9M +7.1% Mar 31, 2013 10-Q/A 2013-05-20
Q4 2012 161M +11.1M +7.44% Dec 31, 2012 10-Q/A 2013-02-22
Q3 2012 158M +12.6M +8.66% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 44.5M -99.1M -69% Jun 30, 2012 10-K/A 2013-10-08
Q1 2012 154M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 150M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 146M Sep 30, 2011 10-Q/A 2011-12-12
Q2 2011 144M Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.